<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; Hepatitis Research</title>
	<atom:link href="http://www.bioscreening.net/category/news/hepatitis-research/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>New Drug Effectively Treats Hepatitis C</title>
		<link>http://www.bioscreening.net/2011/06/23/new-drug-effectively-treats-hepatitis-c/</link>
		<comments>http://www.bioscreening.net/2011/06/23/new-drug-effectively-treats-hepatitis-c/#comments</comments>
		<pubDate>Thu, 23 Jun 2011 20:36:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[FDA News]]></category>
		<category><![CDATA[Hepatitis Research]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[R & D]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1172</guid>
		<description><![CDATA[WEDNESDAY, June 22 (HealthDay News) &#8212; The recently approved drug Incivek, combined with two standard drugs, is highly effective at treating hepatitis C, a notoriously difficult-to-manage liver disease, two new studies show. The drug works not only in patients just starting treatment, but in those who failed earlier treatment, the research found. The hepatitis C [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/23/new-drug-effectively-treats-hepatitis-c/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Evotec Expands Collaboration with InterMune</title>
		<link>http://www.bioscreening.net/2008/03/06/evotec-expands-collaboration-with-intermune/</link>
		<comments>http://www.bioscreening.net/2008/03/06/evotec-expands-collaboration-with-intermune/#comments</comments>
		<pubDate>Thu, 06 Mar 2008 16:32:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Hepatitis Research]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/03/06/evotec-expands-collaboration-with-intermune/</guid>
		<description><![CDATA[Hamburg, Germany &#124; Oxford, UK- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that InterMune, Inc., has signed a second drug discovery contract with Evotec. Evotec will support InterMune&#8217;s research efforts using their medicinal chemistry know-how. In addition, they will utilize their expertise and technologies in computational chemistry, protein production, X-Ray crystallography and ADMET to [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/03/06/evotec-expands-collaboration-with-intermune/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bucks County&#8217;s Institute for Hepatitis and Virus Research and BioLeap Collaborate on New Discoveries</title>
		<link>http://www.bioscreening.net/2007/10/18/bucks-countys-institute-for-hepatitis-and-virus-research-and-bioleap-collaborate-on-new-discoveries/</link>
		<comments>http://www.bioscreening.net/2007/10/18/bucks-countys-institute-for-hepatitis-and-virus-research-and-bioleap-collaborate-on-new-discoveries/#comments</comments>
		<pubDate>Thu, 18 Oct 2007 17:30:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Hepatitis Research]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/18/bucks-countys-institute-for-hepatitis-and-virus-research-and-bioleap-collaborate-on-new-discoveries/</guid>
		<description><![CDATA[New Hope, PA &#8212; (SBWIRE) &#8212; 10/10/2007 &#8212; Bucks Countyâ€™s Institute for Hepatitis and Virus Research (IHVR) and BioLeap have entered into a collaboration to develop new therapeutic compounds for the treatment of Hepatitis C. Up to 50% of patients treated with current standard therapies do not respond adequately and often suffer serious side effects [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/18/bucks-countys-institute-for-hepatitis-and-virus-research-and-bioleap-collaborate-on-new-discoveries/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

